Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $9.56 and traded as low as $7.00. Nxera Pharma shares last traded at $7.13, with a volume of 2,400 shares trading hands.
Nxera Pharma Stock Performance
The stock has a 50 day simple moving average of $9.08 and a 200-day simple moving average of $9.53.
Nxera Pharma Company Profile
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Recommended Stories
- Five stocks we like better than Nxera Pharma
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Options Trading – Understanding Strike Price
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.